Published in Infect Control on February 01, 1984
Mycobacterial cross contamination during radiometric culturing. J Clin Microbiol (1988) 2.56
Contamination of blood cultures during venepuncture: fact or myth? Postgrad Med J (1990) 1.35
Bacillus species pseudobacteremia traced to contaminated gloves used in collection of blood from patients with acquired immunodeficiency syndrome. J Clin Microbiol (1990) 1.15
Pseudoepidemic of Nocardia asteroides associated with a mycobacterial culture system. J Clin Microbiol (1992) 0.88
Skin disease presenting as an outbreak of pseudobacteremia in a laboratory worker. J Clin Microbiol (2001) 0.75
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1993) 6.52
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis (2001) 4.94
Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med (1980) 4.45
Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci (1968) 3.03
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med (1980) 3.03
Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli. J Immunol (1972) 2.89
Limitations of the usefulness of the Limulus assay for endotoxin. N Engl J Med (1973) 2.84
Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med (1989) 2.77
Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis (1978) 2.72
The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA (1998) 2.69
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med (1987) 2.64
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med (1975) 2.63
Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med (1981) 2.56
Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol (1978) 2.44
Type-specific and cross-reactive antibodies in gram-negative bacteremia. N Engl J Med (1972) 2.42
Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis (1994) 2.29
Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore) (1984) 2.28
Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med (1992) 2.25
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol (1999) 2.23
Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med (1988) 2.17
Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis (1980) 2.05
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med (1987) 2.04
Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis (1986) 2.04
Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med (1997) 2.00
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet (1986) 1.96
Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis (1999) 1.75
Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population. J Clin Microbiol (1979) 1.71
Serum complement levels in bacteremia due to gram-negative organisms. N Engl J Med (1973) 1.70
The relation of K-antigen to virulence of Escherichia coli. J Infect Dis (1975) 1.64
Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.59
Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med (1988) 1.58
Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants. Infect Immun (1977) 1.56
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52
Rapid recognition of group B streptococci by pigment production and counterimmunoelectrophoresis. J Clin Microbiol (1976) 1.51
Erythema multiforme associated with bupropion use. Arch Intern Med (2001) 1.50
Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol (1982) 1.45
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn (1996) 1.43
Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model. Infect Immun (1979) 1.41
Nephrotoxicity associated with cephalothin administration. Arch Intern Med (1975) 1.40
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol (1995) 1.40
Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant. Infect Immun (1977) 1.39
Worse six-month outcome for patients with multiple stents in a single coronary artery. J Invasive Cardiol (1999) 1.39
An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA (1980) 1.38
Bacteremia due to Fusobacterium species. Am J Med (1983) 1.35
Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol (2009) 1.33
Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA (1984) 1.31
Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. J Infect Dis (1983) 1.29
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med (1986) 1.29
Common enterobacterial antigen. I. Isolation and purification from Salmonella typhose 0:901. J Immunol (1973) 1.28
"Abacterial" and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen. N Engl J Med (1969) 1.28
A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides. Am J Med (1981) 1.28
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med (1995) 1.27
Meningitis caused by gram-negative bacilli. Ann Intern Med (1980) 1.27
Prolongation of the Q-T interval in man during sleep. Am J Cardiol (1983) 1.25
Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. J Infect Dis (1976) 1.24
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis (1983) 1.24
M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun (1987) 1.24
Nosocomial dermatitis and pruritus caused by pigeon mite infestation. Arch Intern Med (1987) 1.21
Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum. Infect Immun (1987) 1.20
Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J Infect Dis (1987) 1.19
Survey of AIDS knowledge and behavior changes among Massachusetts adults. Prev Med (1989) 1.15
Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med (1984) 1.14
Immunofluorescent demonstration of the common enterobacterial antigen. Proc Soc Exp Biol Med (1966) 1.12
Risk factors for nosocomial pneumonia. Focus on prophylaxis. Med Clin North Am (2001) 1.12
Serogroup identification of meningococci by a modified antiserum agar method. J Clin Microbiol (1979) 1.12
Meningitis caused by Acinetobacter calcoaceticus var anitratus. A specific hazard in neurosurgical patients. Arch Neurol (1981) 1.11
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol (1997) 1.11
Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes. Infect Immun (1982) 1.10
Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs (2001) 1.10
Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria. J Infect Dis (1977) 1.07
Occupational hazards to hospital personnel. Ann Intern Med (1985) 1.07
Knowledge about HIV and behavioral risks of foreign-born Boston public school students. Am J Public Health (1991) 1.07
A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination. Am J Epidemiol (1984) 1.06
Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) (1990) 1.05
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol (1999) 1.05
Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects. J Infect Dis (1988) 1.04
The Boston AIDS Survival Score (BASS): a multidimensional AIDS severity instrument. Am J Public Health (1997) 1.00
Gram-negative bacteremia. Adv Intern Med (1974) 1.00
Use of paper-absorbed fingerstick blood samples for studies of antibody to human immunodeficiency virus type 1 in intravenous drug users. J Infect Dis (1990) 1.00
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making (1998) 0.99
Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol (2001) 0.97
Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol (1995) 0.94
Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazole. J Med Vet Mycol (1996) 0.94